Cat. No.: X25-04-YM989
Lipoic acid agent, Alginate-PEG-lipoic acid, Purity ≥95%
Synonym: Lipoic acid-PEG-alginate
Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
| X25-04-YM989-1 |
PEG 350 Da |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-2 |
PEG 550 Da |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-3 |
PEG 750 Da |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-4 |
PEG 1 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-5 |
PEG 2 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-6 |
PEG 3 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-7 |
PEG 4 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-8 |
PEG 5 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-9 |
PEG 10 kDa |
Alginate |
Lipoic acid |
Inquiry
|
| X25-04-YM989-10 |
PEG 20 kDa |
Alginate |
Lipoic acid |
Inquiry
|
Properties
Description
Alginate-PEG-DOTA, also referred to as DOTA-PEG-alginate, represents a research-grade conjugate where DOTA is covalently bound to alginate (a biocompatible, biodegradable polysaccharide with gelation capability) through a PEG spacer. The PEG component (available in various sizes: 350, 550, 750, 1k, 2k, 3k, 4k, 5k, 10k, or 20k Da) improves solubility, prolongs circulation time, and modulates drug liberation kinetics.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Stability
It is stable under its storage temperature.
Quality Level
Research level
Applications
Alginate-PEG-lipoic acid plays a key role in supporting artificial chaperone systems for protein refolding studies.
Storage
Store at -20°C, protect from light and moisture.
For Research Use Only. Not For Clinical Use.